Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Monnet

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patientsR Arriagada, T Le Chevalier, A Rivière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 studyJ Le Treut, M C Sault, H Lena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2011
Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC studyA Vergnenègre, I Monnet, C Chouaïd, et al.
Revue Des Maladies Respiratoires|June 24, 2010
[Management and outcome of French elderly patients with lung cancer: an IFCT survey]E Quoix, I Monnet, P Scheid, et al.
Revue Des Maladies Respiratoires|December 29, 2000
[Evaluation of occupational exposures in lung cancer]K Legrand Cattan, C Chouaïd, I Monnet, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
The European Respiratory Journal|June 23, 2009
Clinical characteristics and prognostic factors of pulmonary MALT lymphomaR Borie, M Wislez, G Thabut, et al.
BMC Cancer|November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)C Raynaud, L Greillier, J Mazieres, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patientsR Arriagada, T Le Chevalier, A Rivière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2013
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 studyJ Le Treut, M C Sault, H Lena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II studyI Monnet, Cremoux H de, P Soulié, et al.
Lung Cancer (Amsterdam, Netherlands)|May 17, 2011
Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC studyA Vergnenègre, I Monnet, C Chouaïd, et al.
Revue Des Maladies Respiratoires|June 24, 2010
[Management and outcome of French elderly patients with lung cancer: an IFCT survey]E Quoix, I Monnet, P Scheid, et al.
Revue Des Maladies Respiratoires|December 29, 2000
[Evaluation of occupational exposures in lung cancer]K Legrand Cattan, C Chouaïd, I Monnet, et al.
Revue Des Maladies Respiratoires|June 8, 2011
[Effect of tinzaparin on survival in non-small-cell lung cancer after surgery. TILT: tinzaparin in lung tumours]G Meyer, B Besse, S Friard, et al.
The European Respiratory Journal|June 23, 2009
Clinical characteristics and prognostic factors of pulmonary MALT lymphomaR Borie, M Wislez, G Thabut, et al.
BMC Cancer|November 8, 2015
Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)C Raynaud, L Greillier, J Mazieres, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 studyJ B Auliac, C Chouaid, L Greillier, et al.
Pageof 8